Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gil Benedek

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Metabolic Brain Disease|December 16, 2014
The use of flow cytometry to assess a novel drug efficacy in multiple sclerosisGil Benedek, Roberto Meza-Romero, Dennis Bourdette, et al.
Journal of Neuroinflammation|January 27, 2019
A novel neurotherapeutic for multiple sclerosis, ischemic injury, methamphetamine addiction, and traumatic brain injuryArthur A Vandenbark, Roberto Meza-Romero, Gil Benedek, et al.
Neurochemistry International|November 5, 2016
Partial MHC class II constructs as novel immunomodulatory therapy for strokeGil Benedek, Arthur A Vandenbark, Nabil J Alkayed, et al.
Metabolic Brain Disease|February 8, 2016
Predicted structure of MIF/CD74 and RTL1000/CD74 complexesRoberto Meza-Romero, Gil Benedek, Lin Leng, et al.
HLA|July 5, 2019
Identification of the novel HLA-B allele, HLA-B*15:539, in a South-Sudanese individualGil Benedek, Mahmoud Abed El-Latif, Keren Miller, et al.
Journal of Neuroimmunology|July 23, 2015
IL-10 producing B cells partially restore E2-mediated protection against EAE in PD-L1 deficient miceJun Zhang, Gil Benedek, Sheetal Bodhankar, et al.
Journal of Neuroinflammation|January 4, 2024
MIF contribution to progressive brain diseasesAgata Matejuk, Gil Benedek, Richard Bucala, et al.
Journal of Neuroimmunology|December 3, 2019
MIF -173G/C polymorphism is associated with NMO disease severityLivnat Brill, Adi Vaknin-Dembinsky, Omri Zveik, et al.
Journal of Neuroinflammation|June 25, 2015
HLA-DRα1-mMOG-35-55 treatment of experimental autoimmune encephalomyelitis reduces CNS inflammation, enhances M2 macrophage frequency, and promotes neuroprotectionGil Benedek, Roberto Meza-Romero, Kelley Jordan, et al.
Metabolic Brain Disease|July 10, 2017
Estrogen protects both sexes against EAE by promoting common regulatory cell subtypes independent of endogenous estrogenHilary A Seifert, Gil Benedek, Ha Nguyen, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Metabolic Brain Disease|December 16, 2014
The use of flow cytometry to assess a novel drug efficacy in multiple sclerosisGil Benedek, Roberto Meza-Romero, Dennis Bourdette, et al.
Journal of Neuroinflammation|January 27, 2019
A novel neurotherapeutic for multiple sclerosis, ischemic injury, methamphetamine addiction, and traumatic brain injuryArthur A Vandenbark, Roberto Meza-Romero, Gil Benedek, et al.
Neurochemistry International|November 5, 2016
Partial MHC class II constructs as novel immunomodulatory therapy for strokeGil Benedek, Arthur A Vandenbark, Nabil J Alkayed, et al.
Metabolic Brain Disease|February 8, 2016
Predicted structure of MIF/CD74 and RTL1000/CD74 complexesRoberto Meza-Romero, Gil Benedek, Lin Leng, et al.
HLA|July 5, 2019
Identification of the novel HLA-B allele, HLA-B*15:539, in a South-Sudanese individualGil Benedek, Mahmoud Abed El-Latif, Keren Miller, et al.
Journal of Neuroimmunology|July 23, 2015
IL-10 producing B cells partially restore E2-mediated protection against EAE in PD-L1 deficient miceJun Zhang, Gil Benedek, Sheetal Bodhankar, et al.
Journal of Neuroinflammation|January 4, 2024
MIF contribution to progressive brain diseasesAgata Matejuk, Gil Benedek, Richard Bucala, et al.
Journal of Neuroimmunology|December 3, 2019
MIF -173G/C polymorphism is associated with NMO disease severityLivnat Brill, Adi Vaknin-Dembinsky, Omri Zveik, et al.
Journal of Neuroinflammation|June 25, 2015
HLA-DRα1-mMOG-35-55 treatment of experimental autoimmune encephalomyelitis reduces CNS inflammation, enhances M2 macrophage frequency, and promotes neuroprotectionGil Benedek, Roberto Meza-Romero, Kelley Jordan, et al.
Metabolic Brain Disease|July 10, 2017
Estrogen protects both sexes against EAE by promoting common regulatory cell subtypes independent of endogenous estrogenHilary A Seifert, Gil Benedek, Ha Nguyen, et al.
Pageof 4